Molecular basis of atrial fibrillation: A dream or a reality?

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 6, 2003, Pages 667-669

  Van Wagoner, David R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION;

ELECTROPHYSIOLOGY; GENE MUTATION; GENETICS; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; INFLAMMATION; MOLECULAR DYNAMICS; MUSCLE CELL; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SHORT SURVEY; SINUS NODE;

ANIMALS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; ELECTROPHYSIOLOGY; HEART CONDUCTION SYSTEM; HUMANS; OXIDATIVE STRESS; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 0037969739     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.03070.x     Document Type: Short Survey

References (16)

1. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
3. Van Wagoner DR, Nerbonne JM: Molecular basis of electrical remodeling in atrial fibrillation. J Mol Cell Cardiol 2000;32:1101-1117.
4. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL: Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-777.
5. Goette A, Arndt M, Rocken C, Staack T, Bechtloff R, Reinhold D, Huth C, Ansorge S, Klein HU, Lendeckel U: Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 2002;283:H264-H272.
6. Brundel BJ, Ausma J, Van Gelder IC, Van der Want JJ, Van Gilst WH, Crijns HJ, Henning RH: Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 2002;54:380-389.
7. + channels. Cardiovasc Res 2003;57:320-332.
8. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA: Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-180.
9. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR: Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of post-operative atrial fibrillation. Circ Res 2001;89:E32-E38.
10. Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, Wilcox JN, Dudley SC Jr, Harrison DG, Langberg JJ: Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke. Circulation 2002;106:2854-2858.
11. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-369.
12. Chung MK, Martin DO, Wazni O, Kanderian A, Sprecher D, Carnes CA, Bauer JA, Tchou PJ, Niebauer M, Natale A, Van Wagoner DR: C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-2991.
13. Bruins P, Velthuis H, Yazdanbakhsh AP, Jansen PG. van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack CE: Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-3548.
14. Page PL, Plumb VJ, Okumura K, Waldo AL: A new animal model of atrial flutter. J Am Coll Cardiol 1986;8:872-879.
15. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W: KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-254.
16. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, DuBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Marec HL, Bennett V: Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003;421:634-639.